Return On Equity of Neumora Therapeutics, Inc. from 31 Mar 2022 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
Neumora Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2022 to 31 Dec 2025.
- Neumora Therapeutics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -146%, a 112% decline year-over-year.
- Neumora Therapeutics, Inc. annual Return On Equity for 2025 was -146%, a 112% decline from 2024.
- Neumora Therapeutics, Inc. annual Return On Equity for 2024 was -69%, a 101% decline from 2023.
- Neumora Therapeutics, Inc. annual Return On Equity for 2023 was 9737%, a 30203% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Neumora Therapeutics, Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -146% | -77% | -112% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -114% | -40% | -55% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -99% | -38% | -61% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -85% | +29% | +26% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -69% | -9806% | -101% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -74% | -141% | -210% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -61% | -90% | -317% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -114% | -142% | -501% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | 9737% | +9705% | +30203% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | 67% | +59% | +762% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | 28% | +21% | +268% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | 28% | +17% | +141% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | 32% | 01 Oct 2022 | 31 Dec 2022 | ||
| Q3 2022 | 7.8% | 01 Jul 2022 | 30 Sep 2022 | ||
| Q2 2022 | 7.7% | 01 Apr 2022 | 30 Jun 2022 | ||
| Q1 2022 | 12% | 01 Jan 2022 | 31 Mar 2022 |
Neumora Therapeutics, Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -146% | -77% | -112% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -69% | -9806% | -101% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | 9737% | +9705% | +30203% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | 32% | 01 Jan 2022 | 31 Dec 2022 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.